Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.

Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4164659

Similar Items

Correction: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine
by: The Staff
Published: (2014-01-01)

DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine.
by: Fang Liu, et al.
Published: (2014-01-01)

Expression of Concern: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
by: PLOS ONE Editors
Published: (2020-01-01)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
by: Amber Blaauboer, et al.
Published: (2020-09-01)

Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition
by: Venkatasubbaiah A. Venkatesha, et al.
Published: (2012-06-01)

DUSP1 Blocks autophagy-dependent ferroptosis in pancreatic cancer
by: Yangchun Xie, et al.
Published: (2020-09-01)

Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine
by: Hua Li, et al.
Published: (2017-06-01)

Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment
by: Wu LW, et al.
Published: (2019-06-01)

YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine
by: Zhengdong Jiang, et al.
Published: (2016-09-01)

Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine
by: Shangnan Dai, et al.
Published: (2020-01-01)

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
by: Azorsa David O, et al.
Published: (2009-06-01)

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
by: Yunjiang Zhou, et al.
Published: (2019-04-01)

Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation
by: Tang Yong, et al.
Published: (2012-09-01)

Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant
by: Jonathan R. Aspe, et al.
Published: (2014-02-01)

Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
by: Kentaro Minami, et al.
Published: (2015-03-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

Forskolin sensitizes pancreatic cancer cells to gemcitabine via Stat3 and Erk1/2 inhibition
by: Michela Illiano, et al.
Published: (2017-06-01)

Ursolic acid increases drug sensitivity of gemcitabine-resistant human pancreatic cancer cell
by: Zih-Ying Li, et al.
Published: (2019)

Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
by: Concetta Panebianco, et al.
Published: (2021-04-01)

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
by: Ru Chen, et al.
Published: (2017-08-01)

Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways
by: Liang Cheng, et al.
Published: (2018-01-01)

Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
by: Fumihiko Matsuzawa, et al.
Published: (2021-02-01)

Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines
by: Waisse Waissi, et al.
Published: (2021-06-01)

Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells.
by: Yongwei Wang, et al.
Published: (2012-01-01)

HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1Research in context
by: Yanan Lu, et al.
Published: (2019-06-01)

Mechanisms of gemcitabine resistance in pancreatic cancer
by: Melling, J.
Published: (2017)

Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway
by: Changjie Lou, et al.
Published: (2019-01-01)

Polymer coated nanodiamonds as gemcitabine prodrug with enzymatic sensitivity for pancreatic cancer treatment
by: Wanying Ye, et al.
Published: (2020-10-01)

Inactivation of XPF Sensitizes Cancer Cells to Gemcitabine
by: Joseph W. George, et al.
Published: (2019-01-01)

Cytotoxicity of gemcitabine enhanced by polyphenolics from Aronia melanocarpa in pancreatic cancer cell line AsPC-1
by: Thani, Noorr Azela Abdullah, et al.
Published: (2014)

Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair
by: Tasneem Kausar, et al.
Published: (2015-10-01)

YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine
by: Ling Zhou, et al.
Published: (2019-10-01)

Combining gemcitabine with checkpoint kinase inhibitors to sensitize pancreatic tumors
by: Saini, Priyanka
Published: (2015)

Epibrassinolide Promotes the Apoptotic Potential of Gemcitabine in Pancreatic Cancer Cells
by: Fadina Kuryayeva, et al.
Published: (2019-12-01)

Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells
by: Tormod Bjånes, et al.
Published: (2020-02-01)

Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
by: Xu Zhu, et al.
Published: (2018-02-01)

LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
by: Xianbin Zhang, et al.
Published: (2019-11-01)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019-11-01)

Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
by: Manoj Amrutkar, et al.
Published: (2019-06-01)

Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells
by: Kreutzer Jan N, et al.
Published: (2010-08-01)

Cannot write session to /tmp/vufind_sessions/sess_0adu1miv9v6q3t4trbk0fiomqe